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Abstract
Objective: Liver handling of thyroid hormones (TH) has been known to alter significantly during fasting.
This study investigates whether renal handling of TH is also changed during fasting.
Methods: We measured urinary excretion rates and clearances of free tri-iodothyronine (T3) and free
thyroxine (T4) in healthy subjects prior to and on the third day of fasting.
Results: During fasting, both mean T3 and T4 urinary excretion decreased significantly to a mean value
of 42% of control. Also, total and free (F) serum T3 concentrations declined significantly, but serum T4
did not change. Both FT3 and FT4 clearance decreased significantly during fasting (62% and 42% of
control). The fasting-induced decrease in uric acid clearance correlated well with the decrease in FT3
clearance (r = 0.94; P < 0.001). Serum concentrations of non-esterified fatty acids (NEFA) were
significantly elevated during fasting.
Conclusions: The findings cannot be fully explained by the fasting-induced decrease in serum T3, and
are in accordance with inhibition of uptake of T3 and T4 at the basolateral membrane of the tubular
cell. This inhibition may be caused by a decreased energy state of the tubular cell and by other factors
such as ketoacidosis and/or increased NEFA concentrations during fasting.
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Introduction
In man, eighty percent of plasma tri-iodothyronine (T3),
the bioactive thyroid hormone, is produced outside the
thyroid by deiodination of thyroxine (T4), which is the
main secretory product of the thyroid gland (1). Both
liver and kidney cells contain high amounts of the
enzyme, type I 50-deiodinase (2, 3), that converts T4 to
T3. However, before this intracellular conversion can
take place, entry over the plasma membrane into liver
and kidney cells has to occur. We showed that uptake of
T4, but also of T3 and reverse (r) T3 into liver cells is
mediated by an active transport process that is
dependent on ATP and on the Na+-gradient (4). This
process appeared to be the rate-limiting step in the
metabolism of thyroid hormones (5).
During fasting and non-thyroidal illness (NTI), a
decrease in serum T3 concentration, a rise in rT3 and
mostly unchanged free (F) and total (T) serum T4
concentrations are seen (6). These alterations in serum
thyroid hormone levels are explained by unchanged
plasma T4 and rT3 production rates, combined with
both decreased T4 to T3 conversion and rT3 degradation
in the liver (6). In addition to decreased 50-deiodinase
activity, catalyzing both T4 to T3 formation and rT3
degradation (7), decreased uptakes of T4 and rT3 into
the liver have been described as causes for these
alterations (6). In a study using a three compartment
model for thyroid hormone kinetics, we showed that
during caloric deprivation, transport of T4 into the fast
equilibrating compartment (composed of liver and
kidney) was diminished (8), resulting in a decline of
substrate for T3 production and consequently leading to
a lowered plasma T3 production rate.
Much attention has been given to the changes in liver
handling of thyroid hormones seen in NTI and during
fasting (6, 9, 10). However, it is not known whether
changes in renal handling of thyroid hormones occur
during fasting and NTI. In this study, we aim to
illuminate some aspects of renal excretion of thyroid
hormones during fasting in healthy subjects, thus
creating an experimental form of NTI.
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Materials, subjects and methods
Subjects
Four (2 female) healthy volunteers aged 20 to 25 years
participated in this study. Thyroid function as evaluated
by serum concentrations of TT4, FT4, TT3, FT3, rT3 and
thyrotropin (TSH) was normal in all subjects. Apart
from oral contraceptives used by subject 4, no medica-
tion was taken. Indices of nutritional status prior to
the fast were normal in all subjects studied (normal
serum concentrations of T3, creatinine, uric acid, urea
(5.65 6 1.06 mmol/l) and free fatty acids).
Study design
On day 0 a normal diet was consumed. Urine was
collected for 24 h and a blood sample was taken. From
day 1 to 3, the subjects fasted, but a maximal caloric
intake of 60 kcal per day in the form of low fat bouillon
was allowed. On day 3, another 24-h urine sample was
collected and a blood sample was taken. All blood
samples were taken at the mid-point of a 24-h collection
period.
Urine analysis
Samples of the 24-h urine collection were stored at
¹20 8C until analysis. Uric acid, creatinine and urea
concentrations were measured on an EPOS analyzer
from Eppendorf (Hamburg, Germany). Urinary T4 and
T3 concentrations were determined by RIA. Using a
highly specific antibody, no thyroid hormone conjugates
could be measured. In a set of 3 experiments, the
recovery of thyroid hormone added to charcoal-treated
urine was measured. A regression line: y = 0.97x-0.06,
P = 0.04 was obtained. Changing the urinary pH by
adding 50 ml of either 0.1 mol/l NaOH or 0.1 mol/l HCl
to 950 ml urine did not influence the recovery of added
thyroid hormone.
Serum analysis
Serum was stored at ¹20 8C until analysis. Serum TT4,
TT3, and rT3 were determined by RIA. Serum FT4 was
determined using an Amerlite kit from Johnson and
Johnson Clinical Diagnostics Ltd (Amersham, Bucks,
UK). The serum FT3 fraction was determined by
equilibrium dialysis according to Sterling and Brenner
(11), with minor modifications (12). Serum TSH was
determined using a TSH Amerlite kit (Johnson and
Johnson Clinical Diagnostics Ltd). Urea, creatinine and
uric acid were determined on a Chem 1 analyzer from
Technicon (Tarrytown, NY, USA). Serum non-esterified
fatty acids (NEFA) were measured using a NEFA C-test
(Wako Chemicals, Tokyo, Japan).
Calculations and statistical analysis
Clearances of creatinine, uric acid, FT3 and FT4 were
calculated using the formula U*V/P*1.44, where U is
urinary concentration in mol/l, V is urinary volume of
24-h collection period in ml/24 h and P is plasma
concentration in mol/l (13).
The significance of differences was determined
by Student’s t-test for paired observations. All data
are expressed as means 6 S.D. A P value < 0.05 was
considered statistically significant.
Results
Table 1 shows the parameters measured to evaluate
thyroid function before and on the third day of fasting.
Data on all subjects follow the same trend. T3
concentrations are significantly lowered, and those of
rT3 are elevated after fasting. Total and free T4
concentrations are unchanged. Serum TSH levels decline
but all values remain within the reference range.
In Table 2, urinary excretion of T3 and T4 on both the
control day and the third day of fasting are shown.
Urinary excretion of both T3 and T4 is significantly
diminished during fasting. Since urinary excretion is
dependent on the filtration of plasma free hormone,
changes in plasma concentrations will lead to changes
in urinary excretion. Therefore, renal clearances of
FT3 and FT4 are given. In the control period, renal
clearance of FT3 is significantly greater and that of FT4
significantly smaller than the creatinine clearance.
Fasting causes a decline in both renal clearances,
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Table 1 Serum thyroid function parameters prior to and on the third day of fasting. Data
represent the mean 6 S.D. of 4 healthy subjects, except for serum rT3 data: n = 3, before
and on the third day of fasting.
Control Fasting Mean % of control
TSH (mU/l) 0.88 6 0.46 0.37 6 0.23a 42.3
TT4 (nmol/l) 103.3 6 24.8 102.8 6 26.6 99.4
FT4 (pmol/l) 19.4 6 5.4 18.9 6 3.9 98.5
T3 (nmol/l) 1.93 6 0.53 1.29 6 0.32b 67.8
FT3 (pmol/l) 4.2 6 0.6 2.9 6 0.7c 68.2
rT3 (nmol/l) 0.27 6 0.06 0.53 6 0.16d 194.8
a P ¼ 0:0734; b P ¼ 0:0291; c P ¼ 0:0184; d P ¼ 0:05 versus control period data.
resulting in a FT3 renal clearance that is no longer
statistically different from the creatinine clearance
(P = 0.1616).
In Table 3, serum concentrations, 24-h urinary
excretion rates and clearance of uric acid are given.
Serum uric acid concentrations rise significantly during
fasting, but urinary excretion and clearance of uric acid
decrease significantly. Figure 1 shows the correlation
between renal clearances of FT3 and uric acid (r = 0.94,
P < 0.001).
Serum NEFA levels, measured in 3 subjects, rise
significantly after 3 days of fasting (0.27 6 0.22 mmol/l
in the control period versus 1.03 6 0.46 mmol/l in the
fasted state, P = 0.0305).
Discussion
In this study, we investigated renal handling of thyroid
hormones during fasting in man. Our control values of
T4 and T3 excretion and renal clearances of these
hormones in healthy euthyroid persons are in good
agreement with reported values obtained in other studies
(14–20). The FT3 renal clearance in healthy humans is
significantly greater than the creatinine clearance, the
latter being a measure of the glomerular filtration rate
(GFR), whereas FT4 clearance is significantly lower, as
has been found by others (14–20) and in this study.
These data are consistent with active (tubular) excre-
tion of T3 into the urine and effective reabsorption of T4
from the glomerular filtrate in the fed man.
We showed a dramatic decline in urinary excretion of
both T3 and T4 during fasting. Since the urinary fate of a
substance is dependent on its serum concentration,
calculation of the renal clearance is needed to correct
for differences in serum concentrations. When calcu-
lating the renal clearances, we and others (17–20) used
the serum free hormone concentrations since only
the free fraction of these hormones is available for
glomerular filtration and cellular uptake. The decrease
in FT3 and FT4 clearance during fasting indicates that,
in addition to decreased T3 serum concentrations, other
factors are responsible for the lowered excretion of
thyroid hormones into the urine.
Figure 2 depicts a schematic proximal tubule cell of
the kidney. Urinary T3 and T4 may be considered as
the sum of glomerularly filtered thyroid hormone (TH)
(pathway 1), plus TH excreted to the urine (pathway
2), minus reabsorbed TH (pathway 3). Glomerular
filtration of free TH results in a free hormone
concentration, at the start of the proximal tubule,
equal to that in serum. Reabsorption of both T4 and T3
occurs subsequently, but also uptake at the basolateral
membrane of the proximal tubule cell takes place.
Cavalieri et al. (21) showed that, in humans, the
unidirectional renal T3 uptake rate is about 50 nmol
per day. This rate is far greater than the filtered load
per day, which is around 0.8 nmol per day (serum FT3
times GFR, this study). Furthermore, Ferguson et al.
reported unchanged T4 uptake in the isolated perfused
rat kidney after a decrease in the GFR (22). These
observations indicate that thyroid hormones may be
taken up at the basolateral membrane of the tubule
cell and/or in other kidney cells. Thus, in the fed
condition, uptake of TH takes place at both the luminal
membrane (reabsorption, pathway 3) and the baso-
lateral membrane (pathway 4). Deiodination of T4 to
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Table 2 Urinary excretion values (in pmol/24 h) of T4 and T3 and the clearances (in ml/min) of FT3,
FT4 and creatinine prior to and on the third day of fasting. Data represent the mean 6 S.D. of 4
healthy subjects before and on the third day of fasting.
Control Fasting Mean % of control
T3 excretion 1367 6 273 559 6 96a 41.7
FT3 clearance 224.5 6 24.6d 138.8 6 31.2a,f 61.7
T4 excretion 1826 6 702 783 6 535b 41.6
FT4 clearance 70.3 6 35.7e 30.8 6 22.8c 41.9
Creatinine clearance 121 6 6.6 111.7 6 23.0 93.6
a P ¼ 0:007; b P ¼ 0:0123; c P ¼ 0:0231 versus control period data. d P ¼ 0:0048; e P ¼ 0:02;
f P ¼ 0:1616 versus creatinine clearance in the same period.
Table 3 Serum concentrations, 24-h urinary excretion rates and clearance of uric acid (UA) prior
to and on the third day of fasting. Data represent the mean 6 S.D. of 4 healthy subjects before and
on the third day of fasting.
Control Fasting Mean % of control
Serum UA (mmol/l) 0.28 6 0.06 0.46 6 0.07a 168.5
UA excretion (pmol/24 h) 3.37 6 0.82 1.27 6 0.75b 40.6
UA clearance (ml/min) 8.65 6 1.74 2.05 6 1.41c 23.4
a P ¼ 0:0002; b P ¼ 0:009; c P ¼ 0:0049 versus control period data.
T3 (pathway 5), excretion into the urine (pathway 2)
or secretion to the blood (pathway 6) may follow
subsequently.
The lowered excretion and clearances of T3 and T4
during fasting may either be caused by stimulation of
pathway 3, or by a decrease in pathway 2. It is unlikely
that in a state of energy depletion, such as fasting,
pathway 3 will be stimulated, as during caloric depriva-
tion in humans uptake in the rapid equilibrating
compartment (liver and kidney) is decreased (8). There-
fore, a decrease in pathway 2 may be a much more likely
explanation for the findings in this study. In a recent
study, we showed that cellular efflux of thyroid hormones
is a passive process, not influenced by changes in cellular
ATP content, and driven by the intracellular free con-
centration of the hormone (23). Thus, a lowered rate
of efflux via pathway 2 is consistent with a lowered
intracellular free hormone concentration. This may be
explained by a lowered basolateral uptake (pathway 4)
and/or by a lowered luminal uptake (pathway 3).
Inhibition of pathway 3 would result in augmented
excretion of TH into the urine, which is evidently not
the case in our study. Thus, it remains that inhibition of
pathway 4 may be the cause for the decrease in
pathway 2 via a decrease in intracellular free hormone
concentration.
We showed that uptake of T3 is diminished in
perfused livers of fasted rats. Re-perfusion with
energy-enriched perfusion medium restored T3 uptake
within half an hour (7), suggesting involvement of ATP
in the transport process that is being lowered during
fasting. In liver perfusions with fructose in the medium,
ATP concentrations were diminished drastically and T3
uptake decreased in parallel (10). These studies indicate
that cellular ATP is a major determinant of cellular
thyroid hormone uptake, as was found earlier in rat and
human hepatocytes in culture (24, 25). In the present
study, cellular kidney tubular ATP may also be lowered
due to fasting.
As a result of fasting, serum concentrations of NEFA
rise, as reported earlier (26, 27). In a study with obese
subjects undergoing caloric restriction, elevated NEFA
concentrations in the sera of these subjects were found
to be responsible for the inhibited T4 uptake into rat
hepatocytes (27). Thus, elevated NEFA concentrations
may, in addition to lowered cellular energy, be
responsible for the suggested inhibition of pathway 4
(Fig. 2).
In the proximal tubule, uric acid is both actively
reabsorbed and secreted into the urine (28, 29). In the
fasted state, a developed ketoacidemia alters renal
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Figure 1 Plot of the correlation between uric
acid (UA) clearance and FT3 clearance meas-
ured in 4 healthy subjects prior to and on the
third day of fasting. r = 0.94, P < 0.001.
Figure 2 Schematic representation of a proximal tubule cell of
the kidney. N = nucleus. For explanation of the different pathways
(1–6), see Discussion.
clearance of uric acid by an effect on these tubular
transport mechanisms (28, 29). These alterations
cause a lowered urinary excretion, with subsequent
elevated serum concentrations of uric acid (26, 28,
29). The correlation between FT3 renal clearance and
uric acid clearance suggests that tubular handling of
T3 and uric acid may both be affected by similar
mechanisms such as ketoacidosis or a decrease in
cellular energy stores having similar or different
transport pathways.
In this study, we used creatinine clearance (CrCl) as a
marker for GFR, since CrCl values have been shown to
correspond well with measured inulin clearances in
fasting subjects on the third day of fasting in studies by
others (30–32). In the studies of Fox et al. (28) and
Hoffman et al. (33), GFR remains stable over three days
of fasting, as in our study.
One of our subjects used oral contraceptives. These
drugs are known to alter protein binding of thyroid
hormones. Therefore, TT3 and TT4 were elevated,
whereas free concentrations were normal. It can be
questioned whether this medication may have induced
alterations in renal handling of T3 and T4 in one of our
fasting subjects. However, Gaitan et al. (15) reported
unchanged urinary T3 excretion in subjects using oral
contraceptives, so it is unlikely that this drug interfered
in our study, especially since excretion and clearance
values of this subject were comparable to those of the
other subjects.
In conclusion, fasting induced a significant decline in
both T3 and T4 urinary excretion and renal clearances,
which is, in addition to a decrease in serum FT3,
consistent with inhibited uptake of T3 and T4 at the
basolateral membrane of the proximal tubular cell. This
uptake inhibition may be explained by lowered energy
stores of the tubular cells or by other factors such as
ketoacidosis and the detected elevation of serum NEFA
levels.
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